Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential
Cancer Reports · 2025-06 · 8 (6)
DOI: 10.1002/cnr2.70210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, online erschienen am 02.06.2025. Verfasst von Sumaira Anjum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Kinnaird College for Women, Lahore, Pakistan. Hauptthemen laut MEDLINE: Selenium, Neoplasms, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cancer represents a complex group of diseases characterized by abnormal cell proliferation, invasion, and metastasis. These features pose significant challenges to conventional therapeutic approaches, necessitating the development of more targeted and effective treatment strategies.
Objective
This review aims to explore the potential of selenium nanoparticles (SeNPs) as a novel therapeutic tool in cancer treatment, emphasizing their cytotoxic mechanisms and advantages over conventional therapies and other nanoparticles.
Methods
The review synthesizes findings from recent studies investigating the therapeutic properties of SeNPs in cancer models. Emphasis is placed on their ability to selectively target malignant cells, modulate redox status, and influence tumor‐associated cellular processes such as autophagy and microRNA regulation.
Results
SeNPs demonstrate intrinsic antioxidant properties that counteract oxidative stress commonly observed in cancer cells. They modulate critical cellular pathways and exhibit selective toxicity, damaging cancer cells while sparing healthy tissues. Additionally, their biocompatibility and capacity to deliver therapeutic agents contribute to improved safety and efficacy compared to other nanoparticle platforms.
Conclusion
Selenium nanoparticles hold significant promise as a next‐generation cancer treatment modality. Their dual function—serving as both therapeutic agents and drug delivery vehicles—positions them as a powerful tool in precision oncology. By minimizing off‐target effects and enhancing targeted drug delivery, SeNPs have the potential to advance the landscape of cancer theragnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Kinnaird College for Women, Lahore, Pakistan.
- Laboratoire de Biologie Des Ligneux et Des Grandes Cultures, INRAE USC1328, Eure & Loir Campus, University of Orleans, Chartres, France.
- Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
ORCID-Profile: Wisam Nabeel Ibrahim
Zitieren
APA
Anjum, S., Hashim, M., Imran, M., Babur, S., Adnan, S., Hano, C., & Ibrahim, W. N. (2025). Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential. Cancer Reports, 8(6). https://doi.org/10.1002/cnr2.70210
Vancouver
Anjum S, Hashim M, Imran M, Babur S, Adnan S, Hano C, et al. Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential. Cancer Reports. 2025;8(6). doi:10.1002/cnr2.70210
BibTeX
@article{Anjum2025,
author = {Anjum, Sumaira and Hashim, Mariam and Imran, Maham and Babur, Sundus and Adnan, Sanniah and Hano, Christophe and Ibrahim, Wisam Nabeel},
title = {Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential},
journal = {Cancer Reports},
year = {2025},
volume = {8},
number = {6},
doi = {10.1002/cnr2.70210}
}
EUVIMED